JPS60214787A - ピラゾロピリジン誘導体．その製造方法及びその用途 - Google Patents

ピラゾロピリジン誘導体．その製造方法及びその用途

Info

Publication number
JPS60214787A
JPS60214787A JP60031700A JP3170085A JPS60214787A JP S60214787 A JPS60214787 A JP S60214787A JP 60031700 A JP60031700 A JP 60031700A JP 3170085 A JP3170085 A JP 3170085A JP S60214787 A JPS60214787 A JP S60214787A
Authority
JP
Japan
Prior art keywords
formula
hydrogen
compound according
pyrazolo
pyridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP60031700A
Other languages
English (en)
Japanese (ja)
Inventor
ロバート・ウイリアム・ウオード
イアン・ヒユーズ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of JPS60214787A publication Critical patent/JPS60214787A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP60031700A 1984-02-22 1985-02-21 ピラゾロピリジン誘導体．その製造方法及びその用途 Pending JPS60214787A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8404586 1984-02-22
GB848404586A GB8404586D0 (en) 1984-02-22 1984-02-22 Compounds

Publications (1)

Publication Number Publication Date
JPS60214787A true JPS60214787A (ja) 1985-10-28

Family

ID=10556990

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60031700A Pending JPS60214787A (ja) 1984-02-22 1985-02-21 ピラゾロピリジン誘導体．その製造方法及びその用途

Country Status (8)

Country Link
US (1) US4621089A (enExample)
EP (1) EP0154220A3 (enExample)
JP (1) JPS60214787A (enExample)
AU (1) AU3897385A (enExample)
ES (1) ES8605517A1 (enExample)
GB (1) GB8404586D0 (enExample)
GR (1) GR850440B (enExample)
ZA (1) ZA851279B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0193329A3 (en) * 1985-02-22 1987-08-19 Beecham Group Plc Pyrazolopyridines, their preparation and pharmaceutical compositions containing them
AT382377B (de) * 1985-04-27 1987-02-25 Beecham Group Plc Verfahren zur herstellung von neuen 7-substituierten aminopyrazolo(4,3-b)pyridinen
EP0239191A3 (en) * 1986-01-30 1988-07-20 Beecham Group Plc Pyrazolo[4,3-b]pyridine derivatives, process for their preparation and pharmaceutical compositions containing them
GB8609421D0 (en) * 1986-04-17 1986-05-21 Beecham Group Plc Compounds
PE20020506A1 (es) * 2000-08-22 2002-07-09 Glaxo Group Ltd Derivados de pirazol fusionados como inhibidores de la proteina cinasa
ES2245380T3 (es) * 2000-12-15 2006-01-01 Glaxo Group Limited Pirazolopiridinas.
EP1377573B1 (en) * 2000-12-15 2005-07-27 Glaxo Group Limited Pyrazolopyridine derivatives
US7153855B2 (en) * 2001-03-08 2006-12-26 Smithkline Beecham Corporation Pyrazolopyridinyl pyrimidine therapeutic compounds
WO2002078701A1 (en) * 2001-03-30 2002-10-10 Smithkline Beecham Corporation Use of pyrazolopyridines as therapeutic compounds
EP1372643A1 (en) * 2001-03-30 2004-01-02 Smithkline Beecham Corporation Pyrazolopyridines, process for their preparation and use as therapeutic compounds
JP4219171B2 (ja) 2001-04-10 2009-02-04 スミスクライン ビーチャム コーポレーション 抗ウイルス性ピラゾロピリジン化合物
AU2002305143A1 (en) * 2001-04-27 2002-11-11 Smithkline Beecham Corporation Pyrazolo'1,5-a!pyridine derivatives
KR20040018281A (ko) * 2001-06-21 2004-03-02 스미스클라인 비참 코포레이션 포진 바이러스 감염의 예방 및 치료를 위한 이미다조[1，２－α]피리딘 유도체
ES2286272T3 (es) * 2001-09-07 2007-12-01 Smithkline Beecham Corporation Pirizolo-piridinas para el tratamiento de infecciones por herpes.
US7244740B2 (en) * 2001-10-05 2007-07-17 Smithkline Beecham Corporation Imidazo-pyridine derivatives for use in the treatment of herpes viral infection
WO2003050120A1 (en) * 2001-12-11 2003-06-19 Smithkline Beecham Corporation Pyrazolo-pyridine derivatives as antiherpes agents
WO2004033454A1 (en) * 2002-10-03 2004-04-22 Smithkline Beecham Corporation Therapeutic compounds based on pyrazolopyridine derivatives
JP5615274B2 (ja) * 2008-07-01 2014-10-29 ジェネンテック， インコーポレイテッド Ｍｅｋキナーゼインヒビターとしてのイソインドロン誘導体及びその使用方法
CA2727250A1 (en) * 2008-07-01 2010-01-07 Genentech, Inc. Bicyclic heterocycles as mek kinase inhibitors
WO2011056895A1 (en) 2009-11-03 2011-05-12 University Of Notre Dame Du Lac Ionic liquids comprising heteraromatic anions
WO2015048765A1 (en) 2013-09-30 2015-04-02 University Of Notre Dame Du Lac Compounds, complexes, compositions, methods and systems for heating and cooling
WO2015069799A1 (en) 2013-11-05 2015-05-14 University Of Notre Dame Du Lac Carbon dioxide capture using phase change ionic liquids

Also Published As

Publication number Publication date
EP0154220A3 (en) 1986-07-16
ZA851279B (en) 1986-05-28
EP0154220A2 (en) 1985-09-11
GR850440B (enExample) 1985-06-19
ES540610A0 (es) 1986-03-16
AU3897385A (en) 1985-08-29
ES8605517A1 (es) 1986-03-16
US4621089A (en) 1986-11-04
GB8404586D0 (en) 1984-03-28

Similar Documents

Publication Publication Date Title
US4576952A (en) Pyrazolopyridine derivatives and their use as anti-inflammatory and/or anti-allergic agents
KR100219957B1 (ko) 피라졸로 피리딘 화합물 및 그 제조방법
AU656859B2 (en) Aryl group- or aromatic heterocyclic group-substituted aminoquinolone derivatives and anti-HIV agent
US4621089A (en) Pyrazolopyridine derivatives and their use in treating inflammation and allergic conditions
AU2005316668B2 (en) Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as RAF kinase inhibitors
JPH07502742A (ja) Ｐａｆ−レセプタ拮抗剤としてのアミノ酸誘導体
US4670432A (en) Pyrazolopyridine derivatives useful in treating inflammation and allergic conditions
US5464781A (en) Amino naphthyridine compounds as anti-rhoumatic agents
US4684727A (en) Zwitterionic 1,8-naphthyridine and pyrazino[2,3-b]pyridine containing compounds useful as anti-allergic, anti-inflammatory and cycloprotective agents
KR100339059B1 (ko) 이미다조[1,2-a]피리딘의알콕시알킬카르바메이트
JPH083166A (ja) Ｎ‐（ピロロ〔２、３‐ｄ〕ピリミジン‐３‐イルアシル）グルタミン酸誘導体
JPH0232058A (ja) ４―アミノ―３―カルボキシキノリン類およびナフチリジン類、製法および医薬用途
US4782055A (en) Imidazopyridine compounds useful in the treatment of ulcers
RU2738837C2 (ru) Некоторые ингибиторы протеинкиназы
JPH02503318A (ja) 化合物
JP3279633B2 (ja) ピリダジンジオン化合物
WO2009107767A1 (ja) Ｈ４受容体アンタゴニスト作用を有する新規２環性ピリミジン誘導体
EA003941B1 (ru) 2-аминопиридины, содержащие конденсированные кольца в качестве заместителей
AU2002325493B2 (en) Condensed Polycyclic Compounds
US4837238A (en) Pharmacologically useful pyrazolopyridines
US4716160A (en) Certain 7-amino-pyrazolo[4,3-b]pyridines useful in treating inflammatory and allergic disorders
EP0362299A1 (en) Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation
DK164787B (da) 3-substituerede pyrazolooe1,5-aaapyridinderivater, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende et saadant derivat
JPH06505698A (ja) 新規化合物
JP2021512171A (ja) ペンタフルオロスルファニル置換アミド誘導体、そのための製造方法およびその医学的使用